查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800794

脉络膜新生血管市场报告（按产品类型、诊断（萤光素血管摄影、吲哚菁绿血管摄影、光谱域光学相干断层扫描等）、治疗类型、应用和地区）2025 年至 2033 年

Choroidal Neovascularization Market Report by Product Type, Diagnosis (Fluorescein Angiography, Indocyanine Green Angiography, Spectral Domain Optical Coherence Tomography, and Others), Treatment Type, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 124 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球脉络膜新生血管市场规模达 69 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 122 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.13%。

脉络膜新生血管 (CNV) 是指眼部脉络膜层新生血管，影响布鲁赫膜和视网膜色素上皮 (RPE)。其症状包括脂质渗出、视网膜下积血和积液，以及中央视野扭曲、出现波纹和黑点。目前，医生会结合萤光素血管摄影 (FA)、吲哚菁绿 (ICG) 血管摄影和光学相干断层扫描 (OCT) 等技术来诊断 CNV。医生会根据检查结果开立抗血管内皮生长因子 (VEGF) 药物、热雷射治疗和光动力疗法 (PDT)，以阻止血管生长。

由于老年性黄斑部病变 (ARMD)、眼组织胞浆菌病、病理性近视、血管样条纹、脉络膜撕裂以及脉络膜和视网膜发炎性疾病的盛行率不断上升，市场正在经历成长。此外，老年人口的不断增长，使他们更容易患上严重的健康问题，这也是推动市场成长的另一个关键因素。此外，联合用药的日益普及，以及长效抗VEGF药物的推出，正在推动全球对脉络膜新生血管 (CNV) 治疗的需求。医疗基础设施的改善以及研发 (R&D) 活动投资的增加等其他因素也促进了市场的成长。

本报告回答的关键问题：

  • 全球脉络膜新生血管市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对全球脉络膜新生血管市场有何影响？
  • 主要的区域市场有哪些？
  • 根据产品类型，市场是如何分類的？
  • 根据诊断类型，市场是如何分類的？
  • 根据治疗类型，市场是如何分類的？
  • 根据应用，市场细分情况如何？
  • 该产业的价值链分为哪些阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球脉络膜新生血管市场的结构是怎么样的？主要参与者是谁？
  • 产业竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球脉络膜新生血管市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品类型

  • 静脉
  • 玻璃体内

第七章：市场区隔：依诊断类型

  • 萤光素血管摄影（FA）
  • 吲哚菁绿（ICG）血管摄影
  • 频域光学相干断层扫描（OCT）
  • 其他的

第八章：市场区隔：依治疗类型

  • 血管新生抑制剂注射液
  • 光动力疗法
  • 雷射光凝
  • 低剂量放射治疗
  • 手术

第九章：市场区隔：依应用

  • 极度近视
  • 恶性近视变性
  • 与年龄相关的发展

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bausch Health Companies Inc.
    • Bayer AG
    • Gilead Sciences, Inc.
    • F. Hoffmann-La Roche AG
    • MaaT Pharma
    • Novartis AG
    • Pfizer Inc.
    • Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
    • Regeneron Pharmaceuticals Inc.
    • Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
Product Code: SR112025A2561

The global choroidal neovascularization market size reached USD 6.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.13% during 2025-2033.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.

Key Market Segmentation:

Breakup by Product Type:

  • Intravenous
  • Intravitreal

Breakup by Type of Diagnosis:

  • Fluorescein Angiography (FA)
  • Indocyanine Green (ICG) Angiography
  • Spectral Domain Optical Coherence Tomography (OCT)
  • Others

Breakup by Treatment Type:

  • Angiogenesis Inhibitors Injection
  • Photodynamic Therapy
  • Laser photocoagulation
  • Low-dose Radiation Therapy
  • Surgery

Breakup by Application:

  • Extreme Myopia
  • Malignant Myopic Degeneration
  • Age-Related Developments

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Intravenous
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravitreal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis

  • 7.1 Fluorescein Angiography (FA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indocyanine Green (ICG) Angiography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spectral Domain Optical Coherence Tomography (OCT)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Angiogenesis Inhibitors Injection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Photodynamic Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laser Photocoagulation
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Low-dose Radiation Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Extreme Myopia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Malignant Myopic Degeneration
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Age-Related Developments
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Gilead Sciences, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 MaaT Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Regeneron Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
  • Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2024
  • Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
  • Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
  • Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million USD), 2025-2033
  • Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Choroidal Neovascularization Market Structure
  • Table 8: Global: Choroidal Neovascularization Market: Key Players